DAM-57
(Redirected from Dimethyllysergamide)
 | |
 | |
| Clinical data | |
|---|---|
| Other names | DAM-57; N,N-Dimethyllysergamide; DAM; Lysergic acid dimethylamide |
| Routes of administration | Oral[1] |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| E number | {{#property:P628}} |
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C18H21N3O |
| Molar mass | 295.386 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
DAM-57, also known as N,N-dimethyllysergamide (DAM) or as lysergic acid dimethylamide, is a derivative of ergine. There has been a single report of observing N,N-dimethyl-D-lysergamide in the illicit drug market.[2] This compound did induce autonomic disturbances at oral levels of some 10 times the dose required for lysergic acid diethylamide (LSD), presumably in the high hundreds of micrograms. There is some disagreement as to whether there were psychic changes observed.[1] It was first described in the scientific literature by Albert Hofmann and colleagues by 1955.[3]
See also
[edit | edit source]- Substituted lysergamide
- Lysergic acid methylamide (LAM)
- Lysergic acid dipropylamide (DPL)
- Lysergic acid diallylamide (DAL)
References
[edit | edit source]- ^ a b Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).; Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
External links
[edit | edit source] | This hallucinogen-related article is a stub. You can help Wikipedia by expanding it. |